Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124436343 | 12443634 | 3 | F | 20160811 | 20160607 | 20160826 | EXP | CA-BAYER-2016-104932 | BAYER | 42.00 | YR | A | M | Y | 0.00000 | 20160826 | CN | GB | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124436343 | 12443634 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | UNK | Y | 19537 | |||||||||
| 124436343 | 12443634 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | REGULARLY FOR PULMONARY EXACERBATIONS | Y | 19537 | |||||||||
| 124436343 | 12443634 | 3 | SS | OSELTAMIVIR | OSELTAMIVIR | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 124436343 | 12443634 | 4 | SS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 124436343 | 12443634 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 124436343 | 12443634 | 6 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 124436343 | 12443634 | 7 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | UNK | 0 | |||||||||||
| 124436343 | 12443634 | 8 | C | AZTREONAM. | AZTREONAM | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 124436343 | 12443634 | 9 | C | DORNASE ALFA | DORNASE ALFA | 1 | 0 | ||||||||||||
| 124436343 | 12443634 | 10 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | UNK | 0 | |||||||||||
| 124436343 | 12443634 | 11 | C | OMALIZUMAB | OMALIZUMAB | 1 | UNK | 0 | |||||||||||
| 124436343 | 12443634 | 12 | C | CICLESONIDE | CICLESONIDE | 1 | UNK | 0 | |||||||||||
| 124436343 | 12443634 | 13 | C | BUDESONIDE W/FORMOTEROL FUMARATE | BUDESONIDEFORMOTEROL FUMARATE | 1 | UNK | 0 | |||||||||||
| 124436343 | 12443634 | 14 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | UNK | 0 | |||||||||||
| 124436343 | 12443634 | 15 | C | PANCREATIC ENZYMES | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 124436343 | 12443634 | 16 | C | INSULINE NPH | INSULIN PORKINSULIN PURIFIED PORK | 1 | UNK | 0 | |||||||||||
| 124436343 | 12443634 | 17 | C | MULTIVITAMIN | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124436343 | 12443634 | 1 | Influenza like illness |
| 124436343 | 12443634 | 2 | Infective pulmonary exacerbation of cystic fibrosis |
| 124436343 | 12443634 | 3 | Influenza like illness |
| 124436343 | 12443634 | 4 | Infective pulmonary exacerbation of cystic fibrosis |
| 124436343 | 12443634 | 6 | Infective pulmonary exacerbation of cystic fibrosis |
| 124436343 | 12443634 | 7 | Cystic fibrosis |
| 124436343 | 12443634 | 8 | Antibiotic therapy |
| 124436343 | 12443634 | 9 | Inhalation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124436343 | 12443634 | HO |
| 124436343 | 12443634 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124436343 | 12443634 | Staphylococcal sepsis | |
| 124436343 | 12443634 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |